Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp ADR (NQ: AMRN )

1.890 -0.060 (-3.08%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amarin Corp ADR

< Previous 1 2 3 4 5 6 7 Next >
Sarissa Capital Highlights Amarin’s Disregard for Shareholder Interests and Urges Shareholders to Vote the BLUE Proxy Card for Change at Amarin
From Sarissa Capital Management LP
Via Business Wire
Amarin Mails Letter to Shareholders Highlighting New Board and Superior Leadership
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Urges Amarin Shareholders to Vote the Blue Card by February 22 to Fix Amarin for the Benefit of Shareholders
From Sarissa Capital Management LP
Via Business Wire
Amarin Files Definitive Proxy Materials and Mails Letter to Shareholders
From Amarin Corporation plc
Via Globe NewsWire
Why Amarin Stock Tumbled This Week
Amarin's tussle with its largest stakeholder doesn't appear to be sitting well with shareholders. 
Via The Motley Fool
Why Amarin Stock Was a Winner Today
The product most readily identified with the company will soon hit pharmacy shelves in Australia. 
Via The Motley Fool
Amarin (AMRN) Q3 2022 Earnings Call Transcript
AMRN earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand
Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets Since 2022 
From Amarin Corporation plc
Via Globe NewsWire
Amarin to Present at SVB Securities Global Biopharma Conference
From Amarin Corporation plc
Via Globe NewsWire
3 Penny Stocks to Sell in January Before They Peter Out
January has brought a major rally for penny stocks, but these three are likely to see their recent rallies evaporate in the coming weeks. 
Via InvestorPlace
Amarin Calls Activist Investor, Largest Shareholder Sarissa's Statement 'Inaccurate, Misleading'
Amarin Corporation Plc (NASDAQ: AMRN) reacted to its largest shareholder, Sarissa Capital Management, which said Amarin's recent board refreshment put "no shareholder representatives on the board." 
Via Benzinga
Amarin Corp: Q3 Earnings Insights
Amarin Corp (NASDAQ:AMRN) reported its Q3 earnings results on Thursday, October 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Amarin Responds to Inaccurate and Misleading Statement by Sarissa
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Calls Out Amarin’s Sham Board Refreshment
From Sarissa Capital Management LP
Via Business Wire
Amarin Comments on Sarissa’s Notice to Call a Special Meeting of Amarin Shareholders
Highlights Significant Board Refreshment, Operational and Financial Improvements and Engagement with Sarissa Capital Management 
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Submits Notice to Call a Special Meeting of Amarin Shareholders to Add Directors and Remove Chairman Per Wold-Olsen
From Sarissa Capital Management LP
Via Business Wire
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Amarin Provides Preliminary Fourth Quarter and Full Year 2022 Revenue and Cash Position and Priorities for 2023
From Amarin Corporation plc
Via Globe NewsWire
Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP
From Amarin Corporation plc
Via Globe NewsWire
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
 
Via Benzinga
Amarin To Rally 138%? Here Are 10 Other Analyst Forecasts For Friday
 
Via Benzinga
Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Amarin Corporation plc
Via Globe NewsWire
Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland
From Amarin Corporation plc
Via Globe NewsWire
Amarin Announces VAZKEPA® (icosapent ethyl) Approved by the Therapeutic Goods Administration (TGA) in Australia
From Amarin Corporation plc
Via Globe NewsWire
Amarin to Present at Jefferies London Healthcare Conference
From Amarin Corporation plc
Via Globe NewsWire
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870. 
Via Benzinga
Amarin Highlights Key Data Presented at American Heart Association 2022 Scientific Sessions for VASCEPA®/VAZKEPA (icosapent ethyl) and Patient Care
From Amarin Corporation plc
Via Globe NewsWire
Amarin Corp Earnings Perspective: Return On Capital Employed
According to data from Benzinga Pro, during Q3, Amarin Corp's (NASDAQ:AMRN) reported sales totaled $89.88 million. Despite a 92.65% increase in earnings, the company posted a loss of $5.14 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.